Market Research Logo

Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022

Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022

15 to 20 million new cases of cancer are diagnosed every year. Radiotherapy is the gold standard for treatment and is used on more than 3.5 million people and provided as palliative or adjunct treatment for an additional 3.5 million people, worldwide. Nearly 50 percent of all cancer patients are estimated to benefit from radiotherapy for disease management. Radiotherapy is used in cancers that are localized; it can provide excellent control with no recurrence in the treated area. Radiotherapy is also frequently used in combination with surgery or with chemotherapy.

As radiotherapy is a more cost-effective cancer treatment modality, expanding the services of radiotherapy is necessary to providing effective treatment strategies for cancer across care settings. Delivery of radiotherapy with high accuracy and precision—to reduce injury to normal tissues—is the need of the hour. Fiducial markers enable providers to accurately locate tumor lesions and deliver localized and targeted radiotherapy with higher accuracy. Implantation of gold fiducial markers is a cost-effective method. Complications from fiducial marker implantation are not common. Migration of implanted markers is rare and clinically insignificant. Fiducial markers are now considered the standard of care in the delivery of modern prostate RT, and their use is recommended, especially at dose escalation. Fiducials are an excellent surrogate for prostate position and allow for accurate treatment delivery and minimize the effect of radiation on surrounding organs. The main purpose of using fiducial markers is to increase treatment precision where tracking a tumor is difficult. Fiducial markers are commonly used in prostate and lung cancer and are still in the early stages of being used in the treatment of breast, liver and pancreatic cancer.

Lack of clarity on reimbursement, patient selection, lack of training and skill set, and adoption of CBCT are the main challenges to widespread adoption of fiducial markers. On the other hand, easy implantation, low cost, potential for use in future diagnostic purpose, and well-established clinical evidence serve as major driving factors. The research service provides an end-user and market perspective for the use of fiducial markers in US and Europe and provides a five-year forecast from 2017 to 2022. The unique value of this study is that it provides insights gathered from more than 150 end users, including oncologists, interventional radiologists, radiation oncologists, urologists, and pulmonologists. The key applications covered in the report include breast cancer, liver cancer, prostate cancer, lung cancer, and pancreatic cancer. In depth analysis is provided for prostate and lung cancer.


  • Executive Summary-Fiducial Markers Market in the United States and Europe
    • US and European Fiducial Markers Market Summary
    • Research Scope and Segmentation
  • Market Overview of Fiducial Markers in the United States and Europe
    • US and EU Fiducial Markers Market-Cancer Type Snapshot
    • EU and US Fiducial Markers Market-Summary
      • Table Fiducial Markers Market: Market Summary, Europe and US, 2017
  • US Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Analysis
    • Revenue Forecast
    • US Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors for not Using Fiducial Markers-Lung Cancer
    • Key Factors for not Using Fiducial Markers-Prostate Cancer
    • Key Challenges with Existing Fiducial Markers-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Key Criteria for Ideal Fiducial Marker-Lung Cancer
    • Key Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Buying Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • German Fiducial Markers Market
    • Overview
    • Procedural Infrastructure, Prevalence, and Incidence
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting, and Market Share Analysis
    • German Fiducial Markers Market Snapshot
    • German Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • French Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting, and Market Share Analysis
    • French Fiducial Markers Market Snapshot
    • French Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • UK Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting, and Market Share Analysis
    • UK Fiducial Markers Market Snapshot
    • UK Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • Italian Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting and Market Share Analysis
    • Italian Fiducial Markers Market Snapshot
    • Italian Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • Spanish Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting, and Market Share Analysis
    • Spanish Fiducial Markers Market Snapshot
    • Spanish Fiducial Markers Market Explained
    • Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • Fiducial Markers Market
    • Overview
    • Infrastructure, Prevalence, and Incidence Statistics
    • Procedural Volume Breakdown
    • Utilization of Radiotherapy in Cancer Treatment
  • Market Sizing, Forecasting, and Market Share Analysis
    • Swiss Fiducial Markers Market Snapshot
    • Swiss Fiducial Markers Market Explained
    • Swiss Fiducial Markers Market Share Analysis
    • Procedure Cost and Reimbursement
  • End-user Trends and Perspective
    • Cancer Treatment Procedural Volume by Practice Size
    • Budget Allocation and Radiotherapy Procedural Volume
    • Annual Budget Allocation and Spending on Fiducial Markers
    • Introduction of Fiducial Markers to Professionals
    • Services that Professionals Require of Manufacturers
    • Patient Indication for Using Fiducials in Prostate and Lung Cancer
    • Fiducial Marker Usage in the Treatment of Lung Cancer
    • Fiducial Marker Usage in the Treatment of Prostrate Cancer
    • Placement of Fiducial Markers
    • Ideal Fiducial Marker Cost and Patient Adoption
    • Key Factors that Affect Use of Fiducials-Lung Cancer
    • Key Factors that Affect Use of Fiducials-Prostate Cancer
    • Key Challenges with Existing Fiducials-Lung Cancer
    • Key Challenges with Existing Fiducials-Prostate Cancer
    • Important Criteria for Ideal Fiducial Marker-Lung Cancer
    • Important Criteria for Ideal Fiducial Marker-Prostate Cancer
    • Fiducial Marker Type Preferences for Prostate and Lung Cancer
    • End-user Perspective-Liquid Markers
    • End-user Perspective-CBCT
    • Endoscopy Approach and Use of Fiducials in MI Surgery
    • Image Guidance in the Treatment of Cancer
    • Key Brand Selection Criteria
    • Impact of Fiducial Marker Adoption-Applications and Potential Use
  • Growth Opportunities for Success
    • Growth Opportunities Critical for Future Strategy
    • Strategic Imperatives for Success and Growth
  • The Last Word
    • 3 Big Predictions

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report